Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease

Myron F. Weiner, Kevin F. Gray

Research output: Contribution to journalArticlepeer-review

6 Scopus citations


The behavioral and emotional symptoms of Alzheimer's disease (AD) are frequently the most important clinical considerations for physicians, who can choose to employ behavioral/environmental (psychosocial) or psychopharmacologic measures to deal with such symptoms. The appropriate use of these modalities to treat behavioral/emotional symptoms isfacilitated by using a frame of reference that includes information as to where, when, and with whom symptoms occur, with what medication or medical condition, how often, and how troubling or dangerous to patient, caregiver; or others. It should also include patients' ability to communicate, learn and comprehend. This frame of reference can help clinicians appropriately balance their use of psychosocial and psychopharmacologic interventions with AD patients.

Original languageEnglish (US)
Pages (from-to)6-12
Number of pages7
JournalAmerican Journal of Alzheimer's Disease and Other Dementias
Issue number4
StatePublished - Jul 1994

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Psychology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health


Dive into the research topics of 'Balancing psychosocial and psychopharmacologic measures in Alzheimer's disease'. Together they form a unique fingerprint.

Cite this